Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Uremia D014511 33 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Stomach Ulcer D013276 75 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Hypoxia D000860 23 associated lipids
Arrhythmias, Cardiac D001145 42 associated lipids
Hypercalcemia D006934 13 associated lipids
Neovascularization, Pathologic D009389 39 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Han XB et al. Macrophage inflammatory protein-2 mediates the bowel injury induced by platelet-activating factor. 2004 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:15319184
Ma X et al. Platelet-activating factor (PAF) induces corneal neovascularization and upregulates VEGF expression in endothelial cells. 2004 Invest. Ophthalmol. Vis. Sci. pmid:15326102
Wright CS et al. Evidence for lipid packaging in the crystal structure of the GM2-activator complex with platelet activating factor. 2004 J. Mol. Biol. pmid:15327957
Thanou PG and Tsoukatos DC Non-enzymatic platelet-activating factor formation by acetylated proteins. 2004 FEBS Lett. pmid:15327967
Peyman JA et al. HLA-DR genes are silenced in human trophoblasts and stimulation of signal transduction pathways does not circumvent interferon-gamma unresponsiveness. 1992 Transplant. Proc. pmid:1533073
Chou KJ et al. Platelet hyperreactivity in hemodialysis patients with frequently occluded vascular access. 2004 Thromb. Haemost. pmid:15351860
Morita K et al. Development of tactile allodynia and thermal hyperalgesia by intrathecally administered platelet-activating factor in mice. 2004 Pain pmid:15363879
Nemcsik J et al. Synergistic interaction of endogenous platelet-activating factor and vasopressin in generating angina in rats. 2004 Eur. J. Pharmacol. pmid:15363995
Crawford SE et al. Captopril suppresses post-transplantation angiogenic activity in rat allograft coronary vessels. 2004 J. Heart Lung Transplant. pmid:15366425
Testet-Lamant V et al. Enzymatic synthesis of structural analogs of PAF-acether by phospholipase D-catalysed transphosphatidylation. 1992 Biochim. Biophys. Acta pmid:1536875
Seo KH et al. Estrogen enhances angiogenesis through a pathway involving platelet-activating factor-mediated nuclear factor-kappaB activation. 2004 Cancer Res. pmid:15374958
Denizot Y and Nathan N PAF-acether in necrotizing enterocolitis. 1992 Gastroenterology pmid:1537509
Blackburn CC and Selkirk ME Inactivation of platelet-activating factor by a putative acetylhydrolase from the gastrointestinal nematode parasite Nippostrongylus brasiliensis. 1992 Immunology pmid:1537601
Hocking D et al. Dextran sulfate and heparin sulfate inhibit platelet-activating factor-induced pulmonary edema. 1992 J. Appl. Physiol. pmid:1537712
Ranasinghe S and Bolsover S Microglial calcium responses to platelet-activating factor are inhibited by analogue CAS 99103-16-9 and dihydropyridine PCA 4248 but not by ginkgolide A. 2004 Basic Clin. Pharmacol. Toxicol. pmid:15379786
Deryckx S et al. Immunoregulatory functions of paf-acether. VIII. Inhibition of IL-4-induced human IgE synthesis in vitro. 1992 J. Immunol. pmid:1538131
Denizot Y and Nathan N Putative role of platelet-activating factor in the mechanism of virus-induced asthma. 1992 J. Infect. Dis. pmid:1538167
Maier RV et al. Platelet-activating factor augments tumor necrosis factor and procoagulant activity. 1992 J. Surg. Res. pmid:1538603
Hilliquin P et al. Presence of paf-acether in rheumatic diseases. 1992 Ann. Rheum. Dis. pmid:1540032
Hashizume T et al. Sphingosine enhances platelet aggregation through an increase in phospholipase C activity by a protein kinase C-independent mechanism. 1992 Biochem. J. pmid:1540140
Rieves RD et al. Airway epithelial cell mucin release: immunologic quantitation and response to platelet-activating factor. 1992 Am. J. Respir. Cell Mol. Biol. pmid:1540379
Taylor ML et al. The effects of varying doses of aspirin on human platelet activation induced by PAF, collagen and arachidonic acid. 1992 Br J Clin Pharmacol pmid:1540486
Adler KB et al. Inflammatory mediators and the generation and release of reactive oxygen species by airway epithelium in vitro. 1992 Chest pmid:1541206
Kucey DS et al. Platelet-activating factor modulates endotoxin-induced macrophage procoagulant activity by a protein kinase C-dependent mechanism. 1992 Infect. Immun. pmid:1541568
Qian C et al. Metabolism of platelet-activating factor in neutrophils isolated from Pichinde virus-infected guinea pigs. 1992 J. Leukoc. Biol. pmid:1541904
Carceller E et al. 4-substituted 2-alkoxytetrahydrofurans as potent and long-lasting PAF antagonists. 1992 J. Med. Chem. pmid:1542094
Silver RK et al. Amniotic fluid platelet-activating factor (PAF) is elevated in patients with tocolytic failure and preterm delivery. 1992 Prostaglandins pmid:1542743
Chinybaeva LA [Comparative characterization of hemostatic parameters in patients with cerebral stroke]. 2004 Klin Med (Mosk) pmid:15449775
Gambero A et al. Signalling pathways regulating human neutrophil migration induced by secretory phospholipases A2. 2004 Toxicon pmid:15450921
Ma XL et al. Mechanisms of the cardioprotective actions of WEB-2170, bepafant, a platelet activating factor antagonist, in myocardial ischemia and reperfusion. 1992 J. Pharmacol. Exp. Ther. pmid:1545390
Denizot Y et al. Platelet-activating factor and liver metastasis of colorectal cancer. 2005 Int. J. Cancer pmid:15455343
Bonin F et al. Anti-apoptotic actions of the platelet-activating factor acetylhydrolase I alpha2 catalytic subunit. 2004 J. Biol. Chem. pmid:15456758
Alfaro V Role of histamine and platelet-activating factor in allergic rhinitis. 2004 J. Physiol. Biochem. pmid:15457928
Whatley RE et al. Relative amounts of 1-O-alkyl- and 1-acyl-2-acetyl-sn-glycero-3-phosphocholine in stimulated endothelial cells. 1992 Prostaglandins pmid:1546171
Uemura K et al. Superoxide production from human polymorphonuclear leukocytes by human mannan-binding protein (MBP). 2004 Glycoconj. J. pmid:15467404
Lien DC et al. Platelet-activating factor causes neutrophil accumulation and neutrophil-mediated increased vascular permeability in canine trachea. 1992 Am. Rev. Respir. Dis. pmid:1546852
Ais JG et al. [The physiopathology of acute pancreatitis: the role of platelet-activating factor (PAF)]. 1992 Rev Esp Enferm Dig pmid:1547030
Nakagawa K et al. Sperm-immobilizing antibodies suppress an increase in the plasma membrane fluidity of human spermatozoa. 2004 Fertil. Steril. pmid:15474073
Rubin BB et al. Cytosolic phospholipase A2-alpha is necessary for platelet-activating factor biosynthesis, efficient neutrophil-mediated bacterial killing, and the innate immune response to pulmonary infection: cPLA2-alpha does not regulate neutrophil NADPH oxidase activity. 2005 J. Biol. Chem. pmid:15475363
Ko HH et al. Structure-activity relationship studies on chalcone derivatives: potent inhibition of platelet aggregation. 2004 J. Pharm. Pharmacol. pmid:15482650
Angeli V et al. Dyslipidemia associated with atherosclerotic disease systemically alters dendritic cell mobilization. 2004 Immunity pmid:15485633
Ikeuchi H et al. The effects of platelet-activating factor (PAF) and a PAF antagonist (CV-3988) on smoke inhalation injury in an ovine model. 1992 J Trauma pmid:1548723
Nie ZG et al. [Effects of ginkgolide B on lipopolysaccharide-induced TNFalpha production in mouse peritoneal macrophages and NF-kappaB activation in rat pleural polymorphonuclear leukocytes]. 2004 Yao Xue Xue Bao pmid:15491096
Lemieux C et al. Angiopoietins can directly activate endothelial cells and neutrophils to promote proinflammatory responses. 2005 Blood pmid:15498854
Tai H et al. TMVA, a snake C-type lectin-like protein from Trimeresurus mucrosquamatus venom, activates platelet via GPIb. 2004 Toxicon pmid:15501291
Wood JG et al. Gastric microvascular actions of platelet-activating factor: role of leukocytes. 1992 Am. J. Physiol. pmid:1550241
Zang BX et al. [Inhibitory effect of kaempferol against binding of platelet activating factor to its receptor]. 2004 Zhongguo Zhong Yao Za Zhi pmid:15506296
Bankers-Fulbright JL et al. Platelet-activating factor stimulates cytoplasmic alkalinization and granule acidification in human eosinophils. 2004 J. Cell. Sci. pmid:15507482
Renesto P et al. Combined activation of platelets by cathepsin G and platelet activating factor, two neutrophil-derived agonists. 1992 Br. J. Haematol. pmid:1550778
Wegner CD et al. Effects of single and multiple inhalations of platelet-activating factor on airway cell composition and responsiveness in monkeys. 1992 Clin. Exp. Allergy pmid:1551034
Mori TA et al. Differential effect of aspirin on platelet aggregation in IDDM. 1992 Diabetes pmid:1551486
Denizot Y and Chaussade S PAF-acether and diarrhea. 1992 Gastroenterology pmid:1551560
Fujii S et al. Chromogenic assay for the activity of sphingomyelinase from Bacillus cereus and its application to the enzymatic hydrolysis of lysophospholipids. 2004 Biol. Pharm. Bull. pmid:15516713
Suenaga A and Ueki H Effect of orthovanadate on platelet aggregation induced by platelet-activating factor. 2004 Biol. Pharm. Bull. pmid:15516737
Chao W et al. Platelet-activating factor-stimulated protein tyrosine phosphorylation and eicosanoid synthesis in rat Kupffer cells. Evidence for calcium-dependent and protein kinase C-dependent and -independent pathways. 1992 J. Biol. Chem. pmid:1551880
Owen JS et al. An improved assay for platelet-activating factor using HPLC-tandem mass spectrometry. 2005 J. Lipid Res. pmid:15520455
Diez-Fraile A et al. Effect of proinflammatory mediators and glucocorticoids on L-selectin expression in peripheral blood neutrophils from dairy cows in various stages of lactation. 2004 Am. J. Vet. Res. pmid:15524330
Bailly C et al. Platelet activating factor inhibits Cl and K transport in the medullary thick ascending limb. 1992 Kidney Int. pmid:1552700
Mangan NE et al. Helminth infection protects mice from anaphylaxis via IL-10-producing B cells. 2004 J. Immunol. pmid:15528374
Barbanoj MJ et al. Central and peripheral evaluation of rupatadine, a new antihistamine/platelet-activating factor antagonist, at different doses in healthy volunteers. 2004 Neuropsychobiology pmid:15539863
Takeda K [Role of increase in permeability and circulatory failure in the development of organ dysfunction in severe acute pancreatitis]. 2004 Nippon Rinsho pmid:15552880
Takase K et al. [New aspects of pharmaco-therapy for acute pancreatitis]. 2004 Nippon Rinsho pmid:15552891
Bossi F et al. Platelet-activating factor and kinin-dependent vascular leakage as a novel functional activity of the soluble terminal complement complex. 2004 J. Immunol. pmid:15557188
Rothhut B Benveniste's reputation was not written in water. 2004 Nature pmid:15565124
Serradji N et al. Structure-activity relationships in platelet-activating factor. 12. Synthesis and biological evaluation of platelet-activating factor antagonists with anti-HIV-1 activity. 2004 J. Med. Chem. pmid:15566310
Roudebush WE et al. Exposure of preimplantation embryos to platelet-activating factor increases birth rate. 2004 J. Assist. Reprod. Genet. pmid:15568330
Tarricone C et al. Coupling PAF signaling to dynein regulation: structure of LIS1 in complex with PAF-acetylhydrolase. 2004 Neuron pmid:15572112
Ivanov AI et al. Albumin is not an irreplaceable carrier for amphipathic mediators of thermoregulatory responses to LPS: compensatory role of alpha1-acid glycoprotein. 2005 Am. J. Physiol. Regul. Integr. Comp. Physiol. pmid:15576666
Porras-Reyes BH and Mustoe TA Platelet-activating factor: improvement in wound healing by a chemotactic factor. 1992 Surgery pmid:1557687
Cinamon G et al. Chemoattractant signals and beta 2 integrin occupancy at apical endothelial contacts combine with shear stress signals to promote transendothelial neutrophil migration. 2004 J. Immunol. pmid:15585851
Bender A et al. Molecular surface point environments for virtual screening and the elucidation of binding patterns (MOLPRINT 3D). 2004 J. Med. Chem. pmid:15588092
Warringa RA et al. In vivo priming of platelet-activating factor-induced eosinophil chemotaxis in allergic asthmatic individuals. 1992 Blood pmid:1558975
Boschetto P et al. Increase in vascular permeability produced in rat airways by PAF: potentiation by adrenalectomy. 1992 Br. J. Pharmacol. pmid:1559129
Cheng HH et al. Defect in regulation of Ca2+ movement in platelets from patients with systemic lupus erythematosus. 2005 Pharmacology pmid:15591819
Meyniel G et al. [Involvement of PAF (Platelet-Activating Factor) in chloroquine-induced retinopathy]. 1992 C. R. Acad. Sci. III, Sci. Vie pmid:1559183
Connelly PW et al. Paraoxonase-1 does not reduce or modify oxidation of phospholipids by peroxynitrite. 2005 Free Radic. Biol. Med. pmid:15607900
Clement MG et al. PAF and the role of the vagus nerve in the breathing pattern of the pig. 1992 Prostaglandins Leukot. Essent. Fatty Acids pmid:1561234
Binnaka T et al. Burn-induced gastric mucosal hemodynamic disturbance in the rat. Role of platelet-activating factor. 1992 Scand. J. Gastroenterol. pmid:1561532
Li XG and Luo HM [Progress in studies of chemical constituents and pharmacological activities of Kadsura]. 2003 Zhongguo Zhong Yao Za Zhi pmid:15617488
Mann NS and Leung JW Pathogenesis of esophageal rings in eosinophilic esophagitis. 2005 Med. Hypotheses pmid:15617859
Macconi D et al. Defective platelet aggregation in response to platelet-activating factor in uremia associated with low platelet thromboxane A2 generation. 1992 Am. J. Kidney Dis. pmid:1562019
Zhou W et al. Role of platelet-activating factor in pancreatitis-associated acute lung injury in the rat. 1992 Am. J. Pathol. pmid:1562055
Adam K and Oswald I [Triazolam is different: it is a PAF antagonist]. 1992 Anaesthesist pmid:1562092
Denizot Y et al. Platelet-activating factor does not stimulate cAMP formation from immature forms of freshly isolated leukaemic blasts. 2005 Leuk. Lymphoma pmid:15621790
Buduneli E et al. Effects of combined systemic administration of low-dose doxycycline and alendronate on endotoxin-induced periodontitis in rats. 2004 J. Periodontol. pmid:15633329
Nathan N et al. Elevated levels of paf-acether in blood of patients with type 1 diabetes mellitus. 1992 Jan-Feb Diabete Metab pmid:1563539
Penna C et al. Platelet-activating factor induces cardioprotection in isolated rat heart akin to ischemic preconditioning: role of phosphoinositide 3-kinase and protein kinase C activation. 2005 Am. J. Physiol. Heart Circ. Physiol. pmid:15637120
Bate CA et al. Detoxified exoantigens and phosphatidylinositol derivatives inhibit tumor necrosis factor induction by malarial exoantigens. 1992 Infect. Immun. pmid:1563780
Meyer MC et al. Calcium-independent phospholipase A2 is regulated by a novel protein kinase C in human coronary artery endothelial cells. 2005 Am. J. Physiol., Cell Physiol. pmid:15643055
Yoshida H et al. Platelet-activating factor enhances the expression of nerve growth factor in normal human astrocytes under hypoxia. 2005 Brain Res. Mol. Brain Res. pmid:15661369
O'Hair DP et al. Platelet activating factor antagonist RP-59227 reduces vascular injury in discordant cardiac xenograft rejection. 1992 Transplant. Proc. pmid:1566490
Zhu L and He P Platelet-activating factor increases endothelial [Ca2+]i and NO production in individually perfused intact microvessels. 2005 Am. J. Physiol. Heart Circ. Physiol. pmid:15665052
Cuschieri J et al. Calcium/calmodulin-dependent kinase II is required for platelet-activating factor priming. 2005 Shock pmid:15665723
Roudebush WE et al. The significance of platelet-activating factor and fertility in the male primate: a review. 2005 J. Med. Primatol. pmid:15667340
Yoshida H et al. Activity of platelet-activating factor acetylhydrolase exists in red cell membrane. 1992 Am. J. Hematol. pmid:1566749
Morris C et al. Effects of platelet-activating factor on prostaglandin E2 production by intact fetal membranes. 1992 Am. J. Obstet. Gynecol. pmid:1566774
Ottino P et al. PAF-induced furin and MT1-MMP expression is independent of MMP-2 activation in corneal myofibroblasts. 2005 Invest. Ophthalmol. Vis. Sci. pmid:15671273
Murphy CT and Westwick J Selective inhibition of protein kinase C. Effect on platelet-activating-factor-induced platelet functional responses. 1992 Biochem. J. pmid:1567363
Hidalgo MA et al. Andrographolide interferes with binding of nuclear factor-kappaB to DNA in HL-60-derived neutrophilic cells. 2005 Br. J. Pharmacol. pmid:15678086
Oku H et al. Inhibitory effects of xanthones from guttiferae plants on PAF-induced hypotension in mice. 2005 Planta Med. pmid:15678383